|
CDKN1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.58626494956616E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.14559514389157E-11 |
| Normal-vs-Stage2 |
3.66029999998574E-06 |
| Normal-vs-Stage3 |
2.39690489678424E-11 |
| Normal-vs-Stage4 |
4.69150000004248E-06 |
| Stage1-vs-Stage2 |
5.872600E-01 |
| Stage1-vs-Stage3 |
7.798100E-02 |
| Stage1-vs-Stage4 |
9.750400E-01 |
| Stage2-vs-Stage3 |
6.609200E-01 |
| Stage2-vs-Stage4 |
6.462800E-01 |
| Stage3-vs-Stage4 |
2.472000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10331752015236E-12 |
| Normal-vs-AfricanAmerican |
1.319280E-03 |
| Normal-vs-Asian |
1.76943999999901E-05 |
| Caucasian-vs-AfricanAmerican |
1.863980E-01 |
| Caucasian-vs-Asian |
2.193000E-01 |
| AfricanAmerican-vs-Asian |
7.127800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55400000037653E-08 |
| Normal-vs-Female |
6.70652422485318E-12 |
| Male-vs-Female |
3.645800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9718000010549E-08 |
| Normal-vs-Age(41-60Yrs) |
1.05104813741264E-12 |
| Normal-vs-Age(61-80Yrs) |
3.32880000009084E-07 |
| Normal-vs-Age(81-100Yrs) |
7.387300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.581800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.998400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.753200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.449600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.988400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.090400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.299560E-02 |
| Classical-VS-Follicular |
1.825360E-01 |
| Classical-VS-Other |
7.412200E-01 |
| Classical-VS-Normal |
2.78549960874841E-10 |
| Tall-VS-Follicular |
4.058200E-01 |
| Tall-VS-Other |
1.370360E-01 |
| Tall-VS-Normal |
5.29060018017447E-10 |
| Follicular-VS-Other |
5.019400E-01 |
| Follicular-VS-Normal |
6.88279999661034E-08 |
| Other-VS-Normal |
4.324400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10940051484465E-10 |
| Normal-vs-N1 |
1.06340003469541E-09 |
| N0-vs-N1 |
2.038800E-01 |
|
|
